Peyrin-Biroulet L, Hart A, Bossuyt P, Long M, et al. Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial. Lancet Gastroenterol Hepatol 2021 Nov 16. pii: S2468-1253(21)00298.
PMID: 34798039